SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 3-DIMENSIONAL PHARMACEUTICALS (DDDP) -- Ignore unavailable to you. Want to Upgrade?


To: scaram(o)uche who wrote (117)12/6/2002 12:35:55 PM
From: scaram(o)uche  Respond to of 146
 
Dr. David C. U'Prichard, 53............................................................. 1999 2003
Dr. David C. U'Prichard joined us in September 1999 as our Chief Executive
Officer and a member of our Board of Directors. From August 1997 to February
1999, Dr. U'Prichard served as President of Research and Development at
SmithKline Beecham.........


One of biotech's worst CEOs, IMO. And in the opinion of others.

So, Dr. U'Prichard, I have always been a fan of "doubling down" in good companies. Do you have one OUNCE of reason in you, one ounce of RATIONALE, to convince shareholders that you are acting in their best interest? You are, IMO, doing one heck of a shitty job despite that huge salary. Defend yourself.

Why don't you give this last year's salary back to the company? Show some class.

Any number of SI biofreaks could do a better job, mailing in instructions.